These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 16702041)

  • 61. Strong inhibition of fibrinogen binding to platelet receptor alpha IIb beta 3 by RGD sequences installed into a presentation scaffold.
    Lee G; Chan W; Hurle MR; DesJarlais RL; Watson F; Sathe GM; Wetzel R
    Protein Eng; 1993 Sep; 6(7):745-54. PubMed ID: 8248098
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Amino acid structure and characterization of a heterodimeric disintegrin from Vipera lebetina venom.
    Gasmi A; Srairi N; Guermazi S; Dekhil H; Karoui H; El Ayeb M
    Biochim Biophys Acta; 2001 May; 1547(1):51-6. PubMed ID: 11343790
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A cluster of basic amino acid residues in the gamma370-381 sequence of fibrinogen comprises a binding site for platelet integrin alpha(IIb)beta3 (glycoprotein IIb/IIIa).
    Podolnikova NP; Gorkun OV; Loreth RM; Yee VC; Lord ST; Ugarova TP
    Biochemistry; 2005 Dec; 44(51):16920-30. PubMed ID: 16363805
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Hirudisins. Hirudin-derived thrombin inhibitors with disintegrin activity.
    Knapp A; Degenhardt T; Dodt J
    J Biol Chem; 1992 Dec; 267(34):24230-4. PubMed ID: 1447173
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A three-residue cyclic scaffold of non-RGD containing peptide analogues as platelet aggregation inhibitors: design, synthesis, and structure--function relationships.
    Stavrakoudis A; Bizos G; Eleftheriadis D; Kouki A; Panou-Pomonis E; Sakarellos-Daitsiotis M; Sakarellos C; Tsoukatos D; Tsikaris V
    Biopolymers; 2000-2001; 56(1):20-6. PubMed ID: 11582574
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effect of four disintegrins on the adhesive and metastatic properties of B16F10 melanoma cells in a murine model.
    Beviglia L; Stewart GJ; Niewiarowski S
    Oncol Res; 1995; 7(1):7-20. PubMed ID: 7549046
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Inhibition of platelet activation by peptide analogs of the beta(3)-intracellular domain of platelet integrin alpha(IIb)beta(3) conjugated to the cell-penetrating peptide Tat(48-60).
    Dimitriou AA; Stathopoulos P; Mitsios JV; Sakarellos-Daitsiotis M; Goudevenos J; Tsikaris V; Tselepis AD
    Platelets; 2009 Dec; 20(8):539-47. PubMed ID: 19863457
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Design and synthesis of novel cyclic RGD-containing peptides as highly potent and selective integrin alpha IIb beta 3 antagonists.
    Cheng S; Craig WS; Mullen D; Tschopp JF; Dixon D; Pierschbacher MD
    J Med Chem; 1994 Jan; 37(1):1-8. PubMed ID: 7507165
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Interaction of disintegrins with the alpha IIb beta 3 receptor on resting and activated human platelets.
    McLane MA; Kowalska MA; Silver L; Shattil SJ; Niewiarowski S
    Biochem J; 1994 Jul; 301 ( Pt 2)(Pt 2):429-36. PubMed ID: 8042985
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Isolation and Functional Identification of an Antiplatelet RGD-Containing Disintegrin from Cerastes cerastes Venom.
    Ameziani M; Chérifi F; Kiheli H; Saoud S; Hariti G; Kellou-Taîri S; Laraba-Djebari F
    Protein J; 2020 Oct; 39(5):574-590. PubMed ID: 32960374
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Positional importance of Pro53 adjacent to the Arg49-Gly50-Asp51 sequence of rhodostomin in binding to integrin alphaIIbbeta3.
    Chang CP; Chang JC; Chang HH; Tsai WJ; Lo SJ
    Biochem J; 2001 Jul; 357(Pt 1):57-64. PubMed ID: 11415436
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Snake venom disintegrin, saxatilin, inhibits platelet aggregation, human umbilical vein endothelial cell proliferation, and smooth muscle cell migration.
    Hong SY; Koh YS; Chung KH; Kim DS
    Thromb Res; 2002 Jan; 105(1):79-86. PubMed ID: 11864711
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Evaluation of the role of proline residues flanking the RGD motif of dendroaspin, an inhibitior of platelet aggregation and cell adhesion.
    Lu X; Sun Y; Shang D; Wattam B; Egglezou S; Hughes T; Hyde E; Scully M; Kakkar V
    Biochem J; 2001 May; 355(Pt 3):633-8. PubMed ID: 11311124
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Variabilin, a novel RGD-containing antagonist of glycoprotein IIb-IIIa and platelet aggregation inhibitor from the hard tick Dermacentor variabilis.
    Wang X; Coons LB; Taylor DB; Stevens SE; Gartner TK
    J Biol Chem; 1996 Jul; 271(30):17785-90. PubMed ID: 8663513
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Characterization and cDNA cloning of a platelet aggregation inhibitor.
    Koh YS; Kim DS
    Mol Cells; 2000 Aug; 10(4):437-42. PubMed ID: 10987142
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Structural analysis of the KGD sequence loop of barbourin, an alphaIIbbeta3-specific disintegrin.
    Minoux H; Chipot C; Brown D; Maigret B
    J Comput Aided Mol Des; 2000 May; 14(4):317-27. PubMed ID: 10815769
    [TBL] [Abstract][Full Text] [Related]  

  • 77. How snake venom disintegrins affect platelet aggregation and cancer proliferation.
    Kolvekar N; Bhattacharya N; Sarkar A; Chakrabarty D
    Toxicon; 2023 Jan; 221():106982. PubMed ID: 36435228
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A new gene structure of the disintegrin family: a subunit of dimeric disintegrin has a short coding region.
    Okuda D; Koike H; Morita T
    Biochemistry; 2002 Dec; 41(48):14248-54. PubMed ID: 12450389
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Barbourin. A GPIIb-IIIa-specific integrin antagonist from the venom of Sistrurus m. barbouri.
    Scarborough RM; Rose JW; Hsu MA; Phillips DR; Fried VA; Campbell AM; Nannizzi L; Charo IF
    J Biol Chem; 1991 May; 266(15):9359-62. PubMed ID: 2033037
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Sequential 1H NMR assignments of kistrin, a potent platelet aggregation inhibitor and glycoprotein IIb-IIIa antagonist.
    Adler M; Wagner G
    Biochemistry; 1992 Feb; 31(4):1031-9. PubMed ID: 1734953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.